Barclays Reiterates “€40.00” Price Target for Siemens Healthineers (ETR:SHL)

Siemens Healthineers (ETR:SHL) has been assigned a €40.00 ($47.06) price objective by analysts at Barclays in a research note issued on Wednesday, Borsen Zeitung reports. The firm presently has a “neutral” rating on the stock. Barclays‘s price objective points to a potential upside of 6.81% from the company’s current price.

A number of other brokerages have also issued reports on SHL. Nord/LB set a €52.00 ($61.18) target price on shares of Siemens Healthineers and gave the stock a “buy” rating in a research report on Tuesday, August 4th. Sanford C. Bernstein set a €47.00 ($55.29) target price on Siemens Healthineers and gave the company a “buy” rating in a research report on Monday. Royal Bank of Canada set a €45.00 ($52.94) price objective on shares of Siemens Healthineers and gave the stock a “neutral” rating in a report on Tuesday, July 21st. Deutsche Bank set a €40.00 ($47.06) target price on shares of Siemens Healthineers and gave the stock a “neutral” rating in a research note on Monday, August 3rd. Finally, Independent Research set a €39.00 ($45.88) target price on Siemens Healthineers and gave the stock a “neutral” rating in a research report on Friday, September 4th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and seven have issued a buy rating to the stock. Siemens Healthineers has an average rating of “Hold” and an average price target of €42.64 ($50.16).

Shares of Siemens Healthineers stock opened at €37.45 ($44.06) on Wednesday. Siemens Healthineers has a 1 year low of €28.50 ($33.53) and a 1 year high of €47.27 ($55.61). The company has a debt-to-equity ratio of 56.67, a current ratio of 1.31 and a quick ratio of 0.79. The business has a 50-day moving average of €39.13 and a two-hundred day moving average of €40.08. The company has a market capitalization of $37.43 billion and a P/E ratio of 25.34.

Siemens Healthineers Company Profile

Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.

Recommended Story: Return on Equity (ROE)

Analyst Recommendations for Siemens Healthineers (ETR:SHL)

Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.